
    
      100 patients with positive HPV-16 and HPV-18 infection are randomized into interferon gel
      group and control group at ratio of 1:1 (50 patients in treatment group and 50 patients in
      control group). The patients in treatment group received 1g recombinant human Î±-2b interferon
      gel every other day for consecutive 6-10 courses of treatment, whereas no treatment was
      conducted in control group.
    
  